Trial Profile
Safety and efficacy of dual treatment with raltegravir and etravirine in patients with HIV infection.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Feb 2016
Price :
$35
*
At a glance
- Drugs Etravirine (Primary) ; Raltegravir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 29 Feb 2016 New trial record